Sanofi (SNY) Other Operating Expenses (2009 - 2026)

Sanofi has disclosed Other Operating Expenses across 6 years of filings, most recently posting -$1.4 billion for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$1.4 billion, down 60.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.3 billion (down 88.23% YoY), and the FY2025 annual result was -$5.1 billion, down 45.81% from the prior year.
• Other Operating Expenses came in at -$1.4 billion for Q1 2026 at Sanofi, up from -$5.1 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$656.2 million in Q1 2024 to a low of -$5.1 billion in Q4 2025.
• The 4-year median for Other Operating Expenses is -$2.0 billion (2026), against an average of -$2.4 billion.
• Across the five-year window, Other Operating Expenses tumbled 32.57% in 2024 and tumbled 247.97% in 2025, its largest moves.
• Sanofi's Other Operating Expenses stood at -$2.7 billion in 2023, then sank by 32.57% to -$3.5 billion in 2024, then plunged by 45.81% to -$5.1 billion in 2025, then jumped by 72.95% to -$1.4 billion in 2026.
• The last three Other Operating Expenses figures came in at -$1.4 billion (Q1 2026), -$5.1 billion (Q4 2025), and -$3.8 billion (Q3 2025), per Business Quant data.